Single administration of thrombopoietin prevents progression of liver fibrosis and promotes liver regeneration after partial hepatectomy in cirrhotic rats

Annals of Surgery

Volumn 248, Issue 5, 2008, Pages 821-828

  Murata, Soichiro ^a   Hashimoto, Ikuka ^a   Nakano, Yoritaka ^a   Myronovych, Andriy ^a   Watanabe, Motonobu ^a   Ohkohchi, Nobuhiro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; CYTOGLOBIN; PLATELET DERIVED GROWTH FACTOR; RECOMBINANT MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; SCATTER FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; MACROGOL DERIVATIVE; POLYETHYLENE GLYCOL RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; POLYETHYLENE GLYCOL-RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR; RECOMBINANT PROTEIN; THROMBOPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER FUNCTION; LIVER REGENERATION; LIVER STRUCTURE; MALE; NONHUMAN; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; STELLATE CELL; THERAPY EFFECT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT OUTCOME; TREATMENT RESPONSE; ANIMAL; DISEASE COURSE; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; LIVER; LIVER FAILURE; LIVER RESECTION; METABOLISM; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; SPRAGUE DAWLEY RAT;

ANIMALS; DISEASE PROGRESSION; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; LIVER; LIVER CIRRHOSIS; LIVER FAILURE; LIVER REGENERATION; MALE; PLATELET-DERIVED GROWTH FACTOR; POLYETHYLENE GLYCOLS; POSTOPERATIVE COMPLICATIONS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; THROMBOPOIETIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 56149114401     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31818584c7     Document Type: Article

References (47)

1. Pinzani M, Rombouts K. Liver ?brosis: from the bench to clinical targets. Dig Liver Dis. 2004;36:231-242.
2. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg. 1990;211:277-287.
3. Albanis E, Friedman SL. Hepatic ?brosis. Pathogenesis and principles of therapy. Clin Liver Dis. 2001;5:315-334.
4. Ezure T, Sakamoto T, Tsuji H, et al. The development and compensation of biliary cirrhosis in interleukin-6-de?cient mice. Am J Pathol. 2000; 156:1627-1639.
5. Michalopoulos GK, DeFrances MC. Liver regeneration. Science. 1997;276:60-66.
6. Fausto N. Liver regeneration. J Hepatol. 2000;32:19-31.
7. Higgins GM, Anderson RM. Experimental pathology of the liver. Arch Pathol. 1931;12:186-202.
8. Nagasue N, Yukaya H, Ogawa Y, et al. Human liver regeneration after major hepatic resection: a study of normal liver and livers with chronic hepatitis and cirrhosis. Ann Surg. 1987;206:30-39.
9. Azoulay D, Castaing D, Krissat J, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured livers. Ann Surg. 2000;232:665-672.
10. Oe S, Furunaka Y, Hirose T, et al. A trial on regeneration therapy of rat liver cirrhosis by controlled release of hepatocyte growth factor. J Control Release. 2003;88:193-200.
11. Sato M, Kakubari M, Kawamura M, et al. The decrease in total collagen ?bers in the liver by hepatocyte growth factor after formation of cirrhosis induced by thioacetamine. Biochem Pharmacol. 2000;59:681-690.
12. Ozawa S, Uchiyama K, Nakamori M, et al. Combination gene therapy of HGF and truncated type II TGF-β receptor for rat liver cirrhosis after partial hepatectomy. Surgery. 2006;139:563-573.
13. Junbo H, Li Q, Zaide W, et al. Increased level of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis. In Vivo. 1999;13:177-180.
14. Chau GY, Lui WY, Chi CW, et al. Signi?cance of serum hepatocyte growth factor levels in patients with hepatocellular carcinoma undergoing hepatic resection. Eur J Surg Oncol. 2007;34:333-338.
15. Murata S, Ohkohchi N, Matsuo R, et al. Platelets promote liver regeneration in early period after hepatectomy. World J Surg. 2007;31:808-816.
16. Matsuo R, Ohkohchi N, Murata S, et al. Platelets strongly induce hepatocyte proliferation with IGF-1 and HGF in vitro. J Surg Res. 2008;145:279-286.
17. Hoshi R, Murata S, Matsuo R, et al. Freeze dried platelets promote hepatocyte proliferation in mice. Cryobiology. 2007;55:255-260.
18. Lesurtel M, Graf R, Aleil B, et al. Platelet-derived serotonin mediates liver regeneration. Science. 2006;312:104-107.
19. Murata S, Matsuo R, Ikeda O, et al. Platelets promote liver regeneration under conditions of Kupffer cell depletion after hepatectomy in mice. World J Surg. 2008;32:1088-1096.
20. Shibuya K, Akahori H, Takahashi K, et al. Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice. Blood. 1998;91:37-45.
21. Skomorovski K, Harpak H, Ianovski A, et al. New TPO treatment schedules of increased safety and ef?cacy: pre-clinical validation of a thrombopoiesis simulation model. Br J Haematol. 2003;123:683-691.
22. Nagata Y, Nagahisa H, Aida Y, et al. Thrombopoietin induces megakaryocyte differentiation in hematopoietic progenitor FDC-P2 cells. J Biol Chem. 1995;270:19673-19675.
23. Nagata Y, Shozaki Y, Nagahisa H, et al. Serum thrombopoietin level is not regulated by transcription but by the total counts of both megakaryocytes and platelets during thrombocytopenia and thrombocytosis. Thromb Haemost. 1997;77:808-814.
24. McHutchinson JG, Dusheiko G, Shiffman ML, et al. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. N Engl J Med. 2007;357:2227-2236.
25. Je'ze'quel AM, Mancini R, Rinaldesi ML, et al. A morphological study of the early stages of hepatic ?brosis induced by low doses of dimethylni-trosamine in the rat. J Hepatol. 1987;5:174-181.
26. Kaido T, Seto S, Yamaoka S, et al. Perioperative continuous hepatocytes growth factor supply prevents postoperative liver failure in rats with liver cirrhosis. J Surg Res. 1998;74:173-179.
27. Mavier P, Mallat A. Perspectives in the treatment of liver ?brosis. J Hepatol. 1995;22(suppl 2):111-115.
28. Masson S, Scotte M, Garnier S, et al. Differential expression of apoptosis-associated genes post-hepatectomy in cirrhotic vs. normal rats. Apoptosis. 2000;5:173-179.
29. Kaibori M, Kwon AH, Nakagawa M, et al. Stimulation of liver regeneration and function after partial hepatectomy in cirrhotic rats by continuous infusion of recombinant human hepatocytes growth factor. J Hepatol. 1997;27:381-390.
30. Spira G, Mawasi N, Paizi M, et al. Halofuginone, a collagen type I inhibitor improves liver regeneration in cirrhotic rats. J Hepatol. 2002; 37:331-339.
31. Yanagida H, Kaibori M, Hijikawa T, et al. Administration of rhHGF- activator via portal vein stimulates the regeneration of cirrhotic liver after partial hepatectomy in rats. J Surg Res. 2006;130:38-44.
32. Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood. 1997;89:101-107.
33. Jelkmann W. The role of the liver in the production of thrombopoietin compared with erythropoietin. Eur J Gastroenterol Hepatol. 2001;13: 791-801.
34. Martin TG III, Somberg KA, Mebg YG, et al. Thrombopoietin levels in patients with cirrhosis before and after orthopic liver transplantation. Ann Intern Med. 1997;127:285-288.
35. Ishikawa T, Ichida T, Matsuda Y, et al. Reduced expression of throm-bopoietin is involved in thrombocytopenia in human and rat liver cirrhosis. J Gastroenterol Hepatol. 1998;13:907-913.
36. Wolber EM, Ganschow R, Burdelski M, et al. Hepatic thrombopoietin mRNA levels in acute and chronic liver failure of childhood. Hepatology. 1999;29:1739-1742.
37. Schmelzer E, Deiwick A, Bruns H, et al. Thrombopoietin is a growth factor for rat hepatic progenitors. Eur J Gastroenterol Hepatol. 2008; 20:209-216.
38. Nocito A, Georgiev P, Dahm F, et al. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology. 2007;45:369-376.
39. Qi Z, Atsuchi N, Ooshima A, et al. Blockade of type beta transforming growth factor signaling prevents liver ?brosis and dysfunction in the rat. Proc Natl Acad Sci U S A. 1999;96:2345-2349.
40. Nakamura T, Sakata R, Ueno T, et al. Inhibition of transforming growth factor beta prevents progression of liver ?brosis and enhances hepatocytes regeneration in dimethylnitrosamine-treated rats. Hepatology. 2000;32:247-255.
41. Ueki T, Kaneda Y, Tsutsui H, et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med. 1999;5:226-230.
42. Hernandez-Munoz R, Diaz-Munoz M, Suarez-Cuenca JA, et al. Adenosine reverses a preestablished CCl4-induced micronodular cirrhosis through enhancing collagenolytic activity and stimulating hepatocyte cell proliferation in rats. Hepatology. 2001;34:677-687.
43. Sakaida I, Terai S, Yamamoto N, et al. Transdifferentiation of bone marrow cells reduces CCl4-induced liver ?brosis in mice. Hepatology. 2004;40:1304-1311.
44. Yamamoto N, Terai S, Ohata S, et al. A subpopulation of bone marrow cells depleted by a novel antibody, anti Liv8, is useful for cell therapy to repair damaged liver. Biochem Biophys Res Commun. 2004;313:1110-1118.
45. Nakamura T, Torimura T, Sakamoto M, et al. Signi?cance and therapeutic potential of endothelial progenitor cell transplantation in a cirrhotic liver rat model. Gastroenterology. 2007;133:91-107.
46. Ichiba M, Shimomura T, Shiota G, et al. Dual effects of adenovirus-mediated thrombopoietin gene transfer on hepatic oval cell proliferation and platelet counts. Biochem Biophys Res Commun. 2005;335:723-729.
47. Stellos K, Gawaz M. Platelet interaction with progenitor cells: potential implications for regenerative medicine. Thromb Haemost. 2007;98: 922-929.